Inogen Revises Presentation Time at the 40th Annual J.P. Morgan Healthcare Conference
Inogen, Inc. (NASDAQ: INGN) announced that its presentation at the 40th Annual J.P. Morgan Healthcare Conference has been rescheduled to a virtual format. President and CEO Nabil Shabshab will present on January 12, 2022, at 10:30 a.m. ET. Interested investors can access the live audio webcast through the Investor Relations section on the Inogen website. A replay will be available shortly after the live event for 90 days. Inogen specializes in developing and marketing portable oxygen concentrators for patients with chronic respiratory conditions.
- Rescheduled presentation at a prominent healthcare conference increases visibility.
- CEO Nabil Shabshab's participation may boost investor confidence.
- None.
Inogen’s President and CEO,
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.
About Inogen
Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
For more information, please visit www.inogen.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211216005284/en/
Investor and Media Contacts
Inogen-SVC@sardverb.com
(312) 895-4700
Source:
FAQ
When is Inogen's presentation at the J.P. Morgan Healthcare Conference?
How can I access Inogen's presentation?
What company does the stock symbol INGN represent?